| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 143,3 k € | +9.8% | 130,5 k € | ||||||||||||||||
| Gross margin | 141,2 k € | -11.7% | 159,9 k € | +6.9% | 149,6 k € | -15.3% | 176,5 k € | -0.6% | 177,6 k € | +64.3% | 108,1 k € | -5.8% | 114,8 k € | +0.5% | 114,2 k € | +23.2% | 92,7 k € | +1.0% | 91,7 k € | -23.8% | 120,4 k € | -7.0% | 129,5 k € | +35.6% | 95,5 k € | +5.1% | 90,8 k € | +34.4% | 67,6 k € | +3.4% | 65,4 k € | +24.3% | 52,6 k € | |
| EBITDA | 139,2 k € | -11.9% | 158,1 k € | +7.6% | 147,0 k € | -16.0% | 175,0 k € | -0.4% | 175,7 k € | +64.7% | 106,7 k € | -5.8% | 113,2 k € | +0.7% | 112,4 k € | +23.4% | 91,1 k € | +1.0% | 90,2 k € | -24.2% | 119,0 k € | -6.9% | 127,9 k € | +36.2% | 93,9 k € | +5.0% | 89,4 k € | +35.1% | 66,2 k € | +3.5% | 63,9 k € | +29.6% | 49,3 k € | |
| Operating profit | 121,6 k € | -13.5% | 140,6 k € | +11.3% | 126,3 k € | -21.4% | 160,8 k € | -0.6% | 161,7 k € | +74.2% | 92,8 k € | -6.8% | 99,6 k € | +6.6% | 93,4 k € | +27.9% | 73,1 k € | +0.9% | 72,4 k € | -28.7% | 101,5 k € | -7.5% | 109,8 k € | +43.5% | 76,5 k € | +5.8% | 72,3 k € | +45.8% | 49,6 k € | +4.5% | 47,4 k € | +24.4% | 38,1 k € | |
| Profit/loss | 81,5 k € | -8.8% | 89,3 k € | +1.9% | 87,6 k € | -19.1% | 108,4 k € | -12.2% | 123,4 k € | +74.7% | 70,6 k € | -5.9% | 75,0 k € | +23.8% | 60,6 k € | +32.6% | 45,7 k € | +2.2% | 44,7 k € | -26.3% | 60,7 k € | -14.9% | 71,3 k € | +62.9% | 43,8 k € | +2.7% | 42,6 k € | +58.4% | 26,9 k € | +9.0% | 24,7 k € | +4.6% | 23,6 k € | |
| Equity | 764,9 k € | +10.2% | 694,1 k € | +14.8% | 604,8 k € | +16.9% | 517,1 k € | +20.2% | 430,2 k € | +40.2% | 306,8 k € | +29.9% | 236,2 k € | +46.6% | 161,1 k € | +39.5% | 115,5 k € | +65.5% | 69,8 k € | +178.6% | 25,0 k € | -86.8% | 189,3 k € | +60.4% | 118,0 k € | -9.4% | 130,3 k € | +48.6% | 87,6 k € | +44.3% | 60,7 k € | +68.6% | 36,0 k € | |
| Total assets | 876,5 k € | +7.7% | 814,1 k € | +8.3% | 751,6 k € | +27.6% | 588,9 k € | +18.0% | 499,1 k € | +31.2% | 380,4 k € | +15.9% | 328,3 k € | +14.5% | 286,8 k € | +12.2% | 255,7 k € | +5.5% | 242,4 k € | -14.7% | 284,2 k € | -31.7% | 416,5 k € | +16.0% | 359,1 k € | -5.0% | 377,9 k € | -1.5% | 383,8 k € | +0.7% | 381,3 k € | +11.9% | 340,7 k € | |
| Cash | 261,6 k € | +53.6% | 170,3 k € | +230.1% | 51,6 k € | -86.9% | 392,6 k € | +35.9% | 289,0 k € | +49.6% | 193,1 k € | +46.5% | 131,9 k € | +57.1% | 83,9 k € | +255.6% | 23,6 k € | +216.4% | 7,5 k € | -84.7% | 48,7 k € | -69.3% | 158,6 k € | +38.7% | 114,3 k € | +49.7% | 76,4 k € | +9.1% | 70,0 k € | +34.0% | 52,2 k € | +148.9% | 21,0 k € | |
| Debts | 111,6 k € | -7.0% | 120,0 k € | -18.3% | 146,8 k € | +104.4% | 71,8 k € | +4.2% | 68,9 k € | -6.3% | 73,6 k € | -20.2% | 92,2 k € | -26.7% | 125,7 k € | -10.3% | 140,1 k € | -18.8% | 172,6 k € | -33.4% | 259,2 k € | +14.1% | 227,1 k € | -5.8% | 241,0 k € | -2.7% | 247,7 k € | -16.4% | 296,2 k € | -7.6% | 320,6 k € | +5.2% | 304,7 k € | |
Source: Belgian Official Gazette
Private limited company · Liège · incorporated on 22/05/2009
Private limited company profitable and well capitalised. Cash position rising (+53.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
SOCIETE MEDICALE Catherine LEMAIRE is a Private limited company incorporated in 2009. Its main activity is: Other human health activities. Its registered office is in Liège.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.